Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination

Figure 1

Clinical presentation. (a) The maculopapular exanthem at admission. (b) Regression of the maculopapular exanthem after a week. (c) Erythema of the injection site at admission. (d) Injection site after a week. (e) The enanthem at admission. (f) Persistence of enanthem after a week.

(a)

(b)

(c)

(d)

(e)

(f)